- The Vision Council’s research team will present its members with the webinar, “Researching Recovery: Exploring Evolving Consumer Behavior and Industry Response During COVID-19,” on Thursday, May 21 at 12 p.m. EDT. It will examine how the vision industry is responding to the early stages of reopening in some U.S. states, as well as the coinciding changes in consumer sentiment. To register, click here.
- Blanchard Contact Lenses has announced the launch of its new Onefit Spotlight program, designed to highlight the great work of those fitting the Onefit family of scleral lenses. Specifically, practitioners are asked to submit case reports for their Onefit, Onefit MED, Onefit MED+ or Onefit Asian fits using a standardized form. Selected cases will then be posted to the Blanchard website and shared via social media channels, email blasts and partners, such as Contamac, the program’s sponsor. In addition, Blanchard will sponsor some of its favorite cases for submission in the poster presentation at the 2021 Global Specialty Lens Symposium. Visit http://blanchardlab.com/blanchard-u/onefit-spotlight-case-report-program/.
- Eye Designs, LLC has announced the availability of In-Office Sterilization start-up packages, comprised of the environmentally friendly EMIST Electrostatic Sprayers, Clean Republic hypochlorous acid disinfectant and sanitizing solution and in-store messaging to enable business owners to visibly promote their practice as a safe, disinfected environment. Visit www.inofficesterilization.com, email firstname.lastname@example.org or call (800) 346-8890. In other news, the company is providing a virtual gallery of its optical display furnishing collections at
- Graybug Vision, Inc. has appointed Parisa Zamiri M.D., Ph.D., as chief medical officer, effective June 1, 2020. Dr. Zamiri is a physician-scientist with experience in biopharmaceutical and small molecule drug discovery and development, drug and device safety and pharmacovigilance, as well as biomarker development across multiple therapeutic areas. She joins the company from Novartis Pharmaceutical, where she most recently held the position of vice president, global head of Clinical Development and Therapeutic Area Head for Ophthalmology.
- Johnson & Johnson Vision has launched several initiatives to help address the challenges facing eye care professionals (ECPs) and their patients amid the COVID-19 pandemic. These are: offering payment terms extensions, contract extensions and rebate programs, as appropriate; introducing new virtual professional education resources, providing live trainings, webinars and on-demand podcasts to help practitioners stay up-to-date on product innovations, clinical techniques, and resources for small business owners; collaborating with professional bodies worldwide to support optometry students; and providing new digital educational resources and materials for ECPs, consumers, media, and government officials on contact lens safety at https://www.acuvue.com/coronavirus.
- MacuHealth has congratulated Dr. Paul Bernstein and the Bernstein Laboratory for their recent publication in PNAS: https://www.ncbi.nlm.nih.gov/pubmed/32409609. The study demonstrates that meso-zeaxanthin and zeaxanthin are the main carotenoids concentrated at the fovea and that lutein is much more diffuse and at relatively lower concentrations to the zeaxanthins (meso-zeaxanthin and zeaxanthin) in primate retinas.
- Maculogix and MPR, an employee-owned specialty engineering and management services firm, have been recognized with the A’ Design Platinum Award for their work on the AdaptDx Pro guided by Theia medical headset. The Platinum A' Design Award is given to the top 1% of submissions exhibiting an exemplary level of design originality. Visit www.maculogix.com.
- Quidel Corporation received Emergency Use Authorization from the FDA to market its Sofia2 SARS Antigen FIA, a point-of-care test to be used with the Sofia 2 Fluorescent Immunoassay Analyzer for the rapid detection of SARS-CoV-2 in nasal specimens for patients suspected of COVID-19 infection. Visit www.quideleyehealth.com.
- Telasight, inc. has launched a telemedicine platform that provides real time practitioner-to-practitioner consultations, allowing clinical data and images, such as visual fields and OCTs, to be easily shared. The platform, which is 100% HIPAA compliant, is available on Android, iOS and web-based browsers. Unlimited consultations are available with a monthly subscription service at www.telasight.com and users can sign up now to reserve their spot, the company says.
- ThirdEye Gen. Inc., an AR and mixed reality company, has announced it is partnering with NuEyes, a low-vision technology company, to help bring sight to those with visual impairments, such as AMD and glaucoma, that can’t be cured by surgery or conventional glasses. Wearers of ThirdEye’s X2 MR Glasses with NuEye’s software can use voice commands to magnify objects near and far, change contrast and have optical character recognition. Visit https://www.thirdeyegen.com.
- “Open Your Eyes,” a documentary on the role of optometrists as an integral part of health care, will be played again May 26, at 8:00 pm EDT. To register for the encore, visit https://oye.odwire.org.
- Reopeneyecare.com, a new digital platform designed to help eyecare providers navigate the implications of the COVID-19 pandemic on their businesses, has launched. Featuring content specially curated by a taskforce of vision community leaders and sponsored by The Vision Council, the website is intended to serve as a comprehensive resource to help eyecare providers navigate the complex journey from shutdown back to "new normal" business conditions with practical insights and a collection of best practices, protocols, tools and tips for reopening a practice and maintaining its health until conditions improve.
- The National Rosacea Society has announced that new standard management options for rosacea have been published: https://bit.ly/3fXDtjw. As a brief reminder, signs suggestive of ocular rosacea include telangiectasias on the eyelid margin and bloodshot eyes, as well as inflammation and growth of fibrous tissue on the eye. Burning, stinging, light sensitivity and the sensation of a foreign object may also occur, as well as conjunctivitis, inflammation of glands at the rim of the eyelids (blepharitis) and crusty accumulations at the base of the eyelashes.
- Prevent Blindness has declared May 17 to May 23 as “Inherited Retinal Disease Genetic Testing Week” in an effort to educate the public on Inherited Retinal Disease (IRD) and the advantages of genetic testing. Various Shareable social media graphics, a free downloadable fact sheet and a dedicated webpageare available, thanks to a donation by Spark Therapeutics. To download the fact sheet, visit https://preventblindness.org/sites/default/files/national/documents/fact_sheets/2020IRDWeekRelease_V2_Spark.pdf. In other news, Prevent Blindness has released a new logo, program naming system and new website, which contains updated content and enhanced accessibility features (www.PreventBlindness.org). For additional information, view https://youtu.be/XF9m9gWGyks.
- CooperVision has announced that its new Biofinity toric multifocal contact lenses are now available nationwide. The lenses feature four ADD powers for accurate fitting and the company’s Aquaform Technology for breathability and high moisture content. The lenses are available in sphere powers from +10.00 D to -10.00 D (0.50 steps after +/-6.00 D), with cylinder powers from -0.75 D to -5.75 D (0.50 steps), an axis of 5° to 180°in 5° steps, and ADD powers of +1.00 D, +1.50 D, +2.00 D, and +2.50 D, with each ADD available in a D and N lens. Visit https://coopervision.com/practitioner/only-biofinity-toric-multifocal.
- “Myopia Control 2020: Where are we and where are we heading?”, published in in Ophthalmic & Physiological Optics, and written by Drs. Mark Bullimore and Kathryn Richdale, presents a range of critically evaluated safety and efficacy considerations for behavioral, optical and pharmaceutical myopia management pathways. The paper was supported by an educational grant from CooperVision.
- Tusculum University is pausing its efforts to launch the Niswonger College of Optometry, due to COVID-19-driven changes in the optometry delivery care system and likely timetable for the accrediting body that is reviewing Tusculum’s plans.